Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain
- PMID: 32487705
- DOI: 10.1136/rapm-2020-101430
Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain
Keywords: pharmacology: additive agents; pharmacology: local anesthetics; postoperative pain; regional anesthesia; study design.
Conflict of interest statement
Competing interests: KBJ is the executive section editor for Anesthetic Clinical Pharmacology, Anesthesia and Analgesia and is an equity partner for Applied Medical Visualizations.
Comment in
-
Response to the letter to the editor by Hafer and Johnson concerning 'Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain'.Reg Anesth Pain Med. 2020 Dec;45(12):1031-1032. doi: 10.1136/rapm-2020-101488. Epub 2020 Jun 2. Reg Anesth Pain Med. 2020. PMID: 32487703 Free PMC article. No abstract available.
Comment on
-
Mechanism of action of HTX-011: a novel, extended-release, dual-acting local anesthetic formulation for postoperative pain.Reg Anesth Pain Med. 2019 Dec 16:rapm-2019-100714. doi: 10.1136/rapm-2019-100714. Online ahead of print. Reg Anesth Pain Med. 2019. PMID: 31843865
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources